Literature DB >> 22216498

Absorption of drugs by the lung.

G M Shenfield1, M E Evans, J W Paterson.   

Abstract

Ten patients undergoing diagnostic bronchoscopy had radioisotopically labelled drugs put directly into their bronchi; two received sodium cromoglycate, two salbutamol, three salmefamol and three rimiterol. All four drugs were rapidly absorbed but higher peak plasma levels per unit dose were seen with sodium cromoglycate and salbutamol than with the other two drugs. It is suggested that the lung metabolizes salmefamol and rimiterol but does not metabolize salbutamol or sodium cromoglycate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 22216498      PMCID: PMC1428916          DOI: 10.1111/j.1365-2125.1976.tb04879.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  In situ perfusion of isolated rat lung.

Authors:  W P Leary; U Smith
Journal:  Life Sci I       Date:  1970-12-01

2.  The fate of ( 14 C)disodium cromoglycate in man.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

3.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

4.  Absorption of drugs from the rat lung.

Authors:  S J Enna; L S Schanker
Journal:  Am J Physiol       Date:  1972-11

5.  Accumulation of 14 C-imipramine in isolated perfused rat lungs.

Authors:  A F Junod
Journal:  J Pharmacol Exp Ther       Date:  1972-10       Impact factor: 4.030

6.  Pharmacokinetics of inhaled salbutamol in asthmatic patients.

Authors:  M E Evans; J W Paterson; A J Richards; S R Walker
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

7.  The accumulation of 3H noradrenaline by the lung.

Authors:  K Masek; P Svec; A Dlabac; H Raskovă
Journal:  Eur J Pharmacol       Date:  1969-03       Impact factor: 4.432

8.  Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta.

Authors:  S Kalsner
Journal:  Circ Res       Date:  1969-03       Impact factor: 17.367

9.  The metabolism of salbutamol in man.

Authors:  M E Evans; S R Walker; R T Brittain; J W Paterson
Journal:  Xenobiotica       Date:  1973-02       Impact factor: 1.908

10.  Absorption and elimination profile of isoproterenol. I. Anesthetized dogs.

Authors:  H Minatoya; A M Lands; G A Portmann
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

View more
  10 in total

1.  Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man--no evidence of enantioselective lung metabolism.

Authors:  J K Ward; J Dow; N Dallow; P Eynott; S Milleri; G P Ventresca
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

Review 2.  Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

Review 3.  Methods to identify drug deposition in the lungs following inhalation.

Authors:  H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

Review 4.  Adrenergic drugs.

Authors:  C W Bierman
Journal:  Clin Rev Allergy       Date:  1983-03

Review 5.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 6.  Enantioselective disposition of albuterol in humans.

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 7.  Drug therapy approaches in the treatment of acute severe asthma in hospitalised children.

Authors:  L K DeNicola; M O Gayle; K V Blake
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 8.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

9.  Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer.

Authors:  D J Singh; A A Lohade; J J Parmar; Darshana D Hegde; P Soni; A Samad; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

10.  Inhalational system for Etoposide liposomes: formulation development and in vitro deposition.

Authors:  J J Parmar; D J Singh; A A Lohade; Darshana D Hegde; P S Soni; A Samad; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.